Physician profile
Benedict Tiong
NPI 1629415047
$3,274.73
in general payments reported to CMS, 2019-2025
8 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $51.56 · 2021: $250 · 2023: $2,458 · 2024: $36.60 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,400 · Food and Beverage: $183 · Education: $36.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,400.00 |
| Food and Beverage | $183.07 |
| Education | $36.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,668.08 | 2019-2023 | Tavneos, Otezla, Enbrel |
| Glaxosmithkline, LLC. | $125.00 | 2021 | |
| Ucb, INC. | $125.00 | 2025 | Bimzelx |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2021 | |
| Celgene Corporation | $114.73 | 2019 | |
| Janssen Biotech, INC. | $51.56 | 2020 | |
| Pfizer INC. | $36.60 | 2024 | |
| Abbvie INC. | $28.77 | 2023 | Rinvoq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benedict Tiong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.